This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Understand why the SP 500 garners so much attention from investors. A brief look at liquidity, breadth, and what movers it signals.
20,952 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Salesforce faces a growth hurdle in a fast-moving AI world. This article explains how a targeted acquisition could fi...
Gemini Space Station stock dropped sharply after a downgrade spurred by profitability concerns and cautious guidance....
As Johnson & Johnson prepares July earnings, investors weigh the real case buying johnson thesis driven by durable in...
A ChatGPT-style forecast ranks Bitcoin, XRP, and Ethereum for 2026, placing Bitcoin at the top with a sizable upside,...
When a familiar tech name moves lower mid-session, investors want answers. This guide breaks down why intel stock dro...
Moody’s Analytics now sees a near-even chance of a U.S. recession within the next year, as energy shocks and a coolin...
When a shopper’s card data is compromised, banks often trigger rapid fraud alerts. This article breaks down how those...
Pre-marketing for homes, dubbed coming soon listings, has moved from niche tests to a nationwide driver of housing de...
A 75-year-old with $1.3M faces a $58,000 RMD that could tax most of his Social Security, illustrating how tax rules c...
Discover how nyxoah (nyxh) 2025 earnings could shape an investor's view of MedTech plays. This forward-looking analys...
Investors rush to cash in on AI gains even as energy costs, regulatory hurdles, and labor shifts raise the risk profi...